Publications

Books edited

1. Urological Oncology- Vinod H Nargund (London UK), Derek Raghavan (Cleveland, USA) and Howard Sandler (Michigan, USA); Springer UK; 2007-08; Reviewed in New England Journal of Medicine (05.06.2008; Volume 358:2527) p no. 2527; 23
2. Urological Oncology- Vinod H Nargund (London, UK), Derek Raghavan (Charlotte, USA) and Howard Sandler (Los Angeles, USA); Springer UK; 2nd Edition. Published in January 2015. ISBN 978-085729-481-4

Peer-reviewed and commissioned papers

Key publications are marked.

1. Nargund V, Naik KG: Parotid Tumours: Clinico-pathological study. Antiseptic 1981;32: 93-7
2. Schraibman I G, Micheal Z, Nargund VH, Potdar N: Colonoscopic surveillance after diagnosis of carcinoma of colon and rectum. Annales de Chirurgie 1989; 43(7): 568-9.
3. Nargund VH, Lomas K, Sapherson DA, Flannigan GM, Stewart PA: Radiographer- performed abdominal and pelvic ultrasound: Its value in urology out-patient clinic. British Journal of Urology 1994; 73: 366-70 Key publication
4. Nargund VH, Barker IK, Coombs L, Flannigan GM, Hamilton Stewart PA, Crawford SM: Growth characteristics of early passage cell lines compared with established TCC bladder cell lines. Urological Research 1994; 22: 75-7
5. Nargund VH, Hamilton Stewart PA: Point of technique: Endoscopic Localisation of the lesion prior to partial cystectomy. British Journal of Urology 1994; 73(4): 455-6
6. Nargund V H, Hockley I, Flannigan G M: Point of technique: Extracorporeal shock wave lithotripsy for lower ureteric stones through perineal region. British Journal of Urology 1995; 75; 410
7. Nargund V H, Cumming J A, Jerwood D, Sapherson D A, Stewart P A H, Flannigan G M. Ultrasound in urological emergency: results of self audit and implications for training. International Urology and Nephrology1996; 28; 267-71
8. Sugino T, Gorham H, Yoshida K, Boledeoku J, Goodison S, Nargund V, Cranston D, Tarin D. Progressive loss of Cd-44 gene expression in invasive bladder cancer. American Journal of Pathology 1996; 149: 873-882 Key publication
9. Nargund VH and Cranston D W. Urological complications in renal transplantation. Transplant Reviews 1996; 10: 24-33
10. Yoshida K, Sugino T, Tahara H, Nargund VH, Woodman A, Fellows GJ and Tarin D. Telomerase activity in bladder carcinoma and its implications for non-invasive diagnosis by its detection in exfoliated cancer cells in urine. Cancer 1997; 79: 362-9 Key publication
11. Nargund V H, Lowe J, Flanagan G and Hamilton Stewart P. Role of P-Glycoprotein in chemo-resistant superficial bladder tumours. European Urology 1997; 31: 160-2 Key publication
12. Robertson AJ, Nargund V, Gray DWR, Morris PJ. Low dose aspirin as prophylaxis against renal vein thrombosis in renal-transplant patients. Nephrology, Dialysis and Transplantation 2000; 15: 1865-8 Key publication
13. Fenely M, Jan H, Granowska SJ, Mather S, Ellison D, Kirby RS, Oliver RTD, Badenoch DF, Chinegwundoh FC, Nargund VH, Paris AMI, Britton KE. Imaging with prostate specific membrane antigen (PSMA) in prostate cancer. Prostatic carcinoma & Prostatic diseases 2000; 3: 47-52(Review)
14. Nargund V H, Noble J G, Cranston D and Fellows G J. Haematuria: A long-term problem after prostatectomy. Urologia Internationalis 2001; 66: 1-5
15. Ojha K, Nargund V H, Nargund G. Emergency sperm extraction for transient erectile dysfunction prior to assisted conception. Journal of Assisted Reproduction and Genetics 2001;18: 36-7 Key publication
16. Otite U, Webb J A W, Oliver R T D, Badenoch D F and Nargund V H. Testicular microlithiasis: Is it a benign condition with a malignant potential? European Journal of Urology 2001; 40: 538-42 Key publication
17. Goonewardene T I, Bozcuk H, Oliver R T, Barua J, Nargund V and Philip T. Phase 1/2 Study of Synchronous Methotrexate, Cisplatin, Vincristine (MOPq10) Chemotherapy and radiation for patients with locally advanced bladder cancer. Urologia Internationalis 2001; 67: 293-7 Key publication
18. Sohaib A, Theo J, Nargund VH, Hendry WF, Lumley J, Reznek R. Role of MRI in the evaluation of vena caval involvement of renal cell carcinoma. Journal of Urology 2002; 167: 1271-5 Key publication
19. Nargund VH. Management of testicular pain. The Practitioner 2002; 246: 792-800
20. Oliver RTD, Ong J, Berney D, Nargund V, Badenoch D and Samash J. Testis conserving chemotherapy in germ cell cancer: Its potential to increase understanding of the biology and treatment of carcinoma in situ. Acta Pathologica Microbiologica et Immunologica Scandinavia 2003:111: 86-91; discussion 91-2
21. Nargund V H. Editorial comment: Flutamide in recurrent prostate cancer. British Journal of Urology International 2003; 92: 698
22. Oliver R T D, Ong J, Shamash J, Ravi R, Nargund V, Harper P, Ostroveski M J, Sizer B, et al. Long-term follow up of Anglian germ cell cancer group surveillance versus patients with stage I non-seminoma treated with adjuvant chemotherapy. Urology 2004; 63: 556-61 Key publication
23. Hitchings AW, Kumar M, Jordan S, Nargund V, Martin J, Berney D M. Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb. British Journal of Cancer 2004; 91: 552-7 Key publication
24. Lucas M, Stephenson T, Nargund VH. Tamsulosin in the management of patients in acute urinary retention due to BPH. British Journal of Urology International 2005; 95: 354-7 Key publication
25. Nargund VH, Al-Hashimi D, Kumar P, Gordon S, Otite U, Ellison D, Carroll M, Baithun S, Britton K. Imaging with radio-labelled monoclonal antibody (MUJ 591) to prostate-specific membrane antigen (PSMA) in staging of clinically localised prostatic carcinoma: Comparison with clinical, surgical and histological staging. British Journal of Urology International 2005; 95: 1232-6 Key publication
26. Bhardwa JM, Powell R, Berney D, Baithun S, Nargund VH, Oliver RTD. Assessing the size and stage of testicular germ cell tumours 1984-2003. British Journal of Urology International 2005; 96:819-21 Key publication
27. Otite U, Baithun S, Chinegwundoh FC, Nargund VH, Iles RK. Detection of serum and urinary beta human chorionic gonadotrophin (hCGb) in serum or urine is of no clinical significance. Tumor Biology 2006; 27 (4): 181-6
28. Ghani K, Rockall A, Nargund V H, Chinegwundoh F. Comments: Prostate Biopsy: To stop anticoagulation or not? British Journal of Urology International 2006; 97(2): 224-5
29. Kumar P and Nargund V H. Samuel Pepys: A Patient's Perspective of Lithotomy in 17th Century England. Journal of Urology 2006; 175(4): 1221-4 (Review)
30. Kumar P, Kapoor S, Nargund V. Review: Haematospermia. Annals of Royal College of Surgeons of England 2006; 88 (4): 339-42
31. Chinegwundoh FC, Enver MK, Oliver RTD, Nargund VH and Ben-Shlomo Y. Risk and presenting features of prostate cancer amongst African Caribbeans, South Asians and Europeans in Northeast London. British Journal of Urology International 2006; 98:1216-20
32. Kumar P, Nargund VH. Management of post-radical prostatectomy anastomotic stricture by endoscopic transurethral balloon dilatation. Scandinavian Journal of Urology and Nephrology 2007; 41(4): 314-5 Key publication
33. Keeler B, Ghani KR, Nargund VH. Review- Haematuria 1: risk factors, clinical evaluation and laboratory investigations. British Journal of Hospital Medicine 2007; 68(8):418-22
34. Ghani KR, Keeler B, Nargund VH. Review-Haematuria 2: imaging investigations, management and follow up. British Journal of Hospital Medicine 2007; 68: 489-493
35. Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Metcalfe C, Persad R on behalf of the PROCESS study group. The risk of prostate cancer amongst Black men in the United Kingdom: The PROCESS retrospective cohort study. European Urology 2008; 53(1):99-105. Epub 2007 Mar 1 Key publication
36. Haba Y, Williams MV, Neal DE, Ong JY, Ostrowski MJ, Ell PJ, Nargund V, Shamash J, Oliver RT. Stage migration and pilot studies of reduced chemotherapy supported by positron-emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumour. British Journal of Urology International 2008; 101(5): 570-4 Key publication
37. Nargund VH and Grey A. Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses. Expert Opinion on Pharmacotherapy 2008; 9: 813-824
38. Nargund VH. Editorial Comment on ‘A Five-year follow up study of asymptomatic men with testicular microlithiasis’. Journal of Urology 2008; 179: 1423
39. Nargund VH. Review: Health Issues of Cycling in Men. British Journal of Urology International 2008; 102(7):771-2 Epub 2008 Jun 28. Press Release on 07.07.2008 Key publication
40. Metcalfe C, Patel B, Evans S, Ibrahim F, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Persad R, Ben-Shlomo Y. The risk of prostate cancer amongst South Asian men in southern England: The PROCESS cohort study. British Journal of Urology International 2008; 102(10):1407-12. Epub ahead of print 6 June Key publication
41. Metcalfe C, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Persad R, Ben-Shlomo Y. Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort study. British Journal of Cancer. 2008; 99(7):1040-5 [Epub ahead of print] Press Release 29.09.2008 Key publication
42. Evans S, Metcalfe C, Patel B, Ibrahim F, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Wilson P, Persad R, Ben-Shlomo Y. Clinical presentation and initial management of Black men and White men with prostate cancer in the United Kingdom: the PROCESS cohort study. British Journal of Cancer 2010;102(2): 249-54. Epub 2009 Nov 24.
43. Kumar P, Mehta V, Nargund V. Management of Chronic testicular pain. Urologia Internationalis 2010; 84(2); 125-31
44. Nargund V and Zaman F. Radical prostatectomy: too soon to abandon the perineal approach? (Perineal radical prostatectomy versus endoscopic retropubic prostatectomy). Nature Urology Reviews 2011; 8: 179-180
45. Tanabalan C, Kabir M and Nargund V H. Management of Non-muscle Invasive Bladder Cancer (NMIBC). Seminars in Oncology 2012; 39: 559-72
46. Nargund V H. Effects of psychological stress on male fertility. Nature Urology Reviews 2015; 12: 373-82
47. Turner B, Ali S, Drudge-Coates L, Pati J, Nargund V, Wells P. Skeletal Health Part 1: Overview Of Bone Health and Management In the Cancer Setting. Urol Nurs 2016; 36(1):17-21
48. Turner B, Ali S, Drudge-Coates L, Pati J, Nargund V, Wells P. Skeletal Health Part 2: Development of a Nurse Practitioner Bone Support Clinic for Urologic Patients. Urol Nurs 2016; 36(1): 22-6

Book chapters, patient booklets and proceedings

1. Nouri AME, Oliver RTD, Nargund V. Clonal development of bladder cancer and its relevance to the Clinical potential of HLA antigen and p53 based gene therapy. In: Cancer Surveys in Bladder Cancer (Volume 31). Oliver RTD and Coptcoat M (Eds.): Imperial Cancer Research Fund, London (1998). 109-128
2. Oliver RTD, Badenoch DF, Nargund V, Sohaib SA, et al. Chemotherapy for testis conservation in patients with germ cell tumours: Is it safe and could combination with tumour enucleation increase the frequency of success? Germ Cell Tumours V: Proceedings of the 5th International Germ Cell Tumour Conference, University of Leeds. 2001. Harnenden P, Joffe J and Jones J (Eds). Springer UK (2001)
3. Oliver RTD, Lane T, Wells P, Chinegwundoh FC, Nargund V H. Medical interventions relevant in prevention and management of early prostate Cancer: a new potential role for GPs, schools and works’ medical officers, as well as STD, family planning and infertility clinics. In: The Effective Management of Prostate Cancer. Wallace DMA, Oliver RTD, Ash D and Miles A (Eds). Aesculapius Medical Press, London (2002) ISBN 1 903044 25 1 Soft back
4. Booklet BACUP Series for Cancer Patients: Cancer of the kidney. July 2004
5. Booklet BACUP Series for Cancer Patients: Testicular Cancer. December 2005, 2009
6. Oliver RTD, Ong J, Berney D, Nargund V, Badenoch D, Shamash J. Testis conserving chemotherapy in germ cell cancer: Its potential to increase understanding of the biology and treatment of carcinoma in situ. In: Testicular Germ Cell Neoplasia: A Developmental Disease? Rajpert-De Meyts E, Grigor KM, Skakkebaek NE (Eds.). Blackwell, Munksgaard (2003); 86-92
7. Ghani K and Nargund VH. Chapter 3: Haematuria and Haematospermia. In Urological Oncology Nargund VH, Raghavan D and Sandler H M (Eds), Springer UK, London (2007); 107-121.
8. Oliver RTD, Shamash J, Nargund VH. Chapter 17.1 Testicular- Germ Cell Tumours. In Urological Oncology. Nargund V H, Raghavan D and Sandler H M(Eds), Springer UK, London (2007); 401-444
9. Kumar P and Nargund V H. Urethral cancer (excluding penile cancer). In Urological Oncology by Nargund V H, Raghavan D and Sandler H (Eds), Springer UK, London (2007); 390-400
10. Nargund V H. Chapter 18.2. Clinical presentation, Diagnosis and Staging of Prostate Cancer. In Urological Oncology by Nargund V H, Raghavan D and Sandler H (Eds), Springer UK, London (2007); 470-481
11. Nargund V. Chapter 18.3. Surgical Management of Carcinoma of Prostate. In Urological Oncology by Nargund V H, Raghavan D and Sandler H M (Eds), Springer UK, London (2007); 482-496
12. Oliver RTD, Powles T, Nargund V, Berney D. Chapter 22: Spontaneous Regression of Renal Cell Cancer and the Role of Prognostic Factors. In Clinical Management of Renal Tumours: Bukowski R M, Novick A (Eds.) 2008, 665 p. 174 illus., Hardcover; ISBN: 978-1-58829-251-3 Humana Press
13. Klinefelter Syndrome Association UK Literature: V. Nargund- Orchidectomy, Testicular Cancer and Testicular Prosthesis 2007
14. Nephrostomy for Cancer-Macmillan Cancer Support 2012
15. TCC Renal Pelvis & Ureter- Macmillan Cancer Support 2012
16. RCC Macmillan Cancer Support 2012
17. Nephrostomy and its care. Macmillan Cancer Support 2014.
18. Alleemudder A, Seth A & Nargund VH. Chapter 18: Renal cancer- Epidemiology and Aetiology. In Nargund VH, Raghavan D and Sandler H (Eds) Urological Oncology 2nd edition Springer 2015 p.no 345-352
19. Alleemudder A, Nargund VH & Seth A. Chapter 20: Renal Cancer: Clinical features. In Nargund VH, Raghavan D and Sandler H (Eds) Urological Oncology 2nd edition. Springer 2015. p.no. 367-372
20. Alleemudder A & Nargund VH. Chapter 22: Renal Cancer- Surgical management. In Nargund VH, Raghavan D and Sandler H (Eds) Urological Oncology 2nd edition. Springer 2015. p.no. 383-394
21. Kumar P & Nargund V H. Chapter 38: Urachal and Urethral Cancer. In Nargund VH, Raghavan D and Sandler H (Eds) Urological Oncology 2nd edition. Springer 2015. p.no. 663-676
22. Nargund V H. Surgical aspects of prostate cancer management. In Nargund VH, Raghavan D and Sandler H (Eds) Urological Oncology 2nd edition. Springer 2015. p.no. 799-806
23. Nargund V H. Patient information on Late Effects of Radiationpelvic/bowel. Macmillan Cancer Support July 2017

Case reports and letters

1. Nargund VH, Andrews NJ, Higham A: Intermittent brachial embolism. European Journal of Vascular Surgery 1987; 1: 423-6
2. Nargund V H, O'Sullivan D C and O'Riordan M: Extravasation of urine due to phimosis. British Journal of Sexual Medicine 1990; 4: 93
3. Nargund VH, Gouldesbrough D and Hamilton Stewart P A: A Self-made diagnosis of phaeochromocytoma of the Urinary Bladder. British Journal of Urology 1994; 73: 220-2
4. Nargund V, Donaldson RA: Urachal Calculi. International Urology and Nephrology 1994; 26: 409-11
5. Nargund V H and Hamilton Stewart P A: Acute bacterial prostatitis with osteomyelitis. Journal of the Royal Society of Medicine 1995; 88: 355-6
6. Crew JC, Nargund VH and Fellows GJ: Symptomatic urethral hairball and diverticulum as a complication of island urethroplasty. Scandinavian Journal of Urology & Nephrology 1996; 30: 231-3
7. Khan M, Hellawell G and Nargund VH. Ureteric Obstruction due to non-Hodgkin’s lymphoma. International Journal of Urology and Nephrology 1997; 29: 541-2
8. Naseem S, Jan K, Britton K and Nargund VH. Splenic metastasis from adenocarcinoma of prostate. British Journal of Urology 1998; 82: 597-8
9. Chan L, Otite U and Nargund V H. An unusual cause of tenesmus. British Journal of Urology International 1999; 84: 741-2
10. Otite U, Nambirajan T, Berney DM, Badenoch DF, Nargund VH. Testicular Seminoma diagnosed by annual ultrasound surveillance for testicular microlithiasis. British Journal of Urology 2000;86: 4-5
11. Mahesh Kumar, Gordon S, Otite U and Nargund VH. Testicular Tumour presenting as haematospermia. Journal of Urology 2001; 165:188
12. Otite U, Galloway M, Baithun S, Akbar S and Nargund V H. Fibrous tumour of the kidney. British Journal of Urology International 2001; 87: 714
13. Gordon S, Mahesh Kumar, Cannon P and Nargund V H: The role of scrotal ultrasound in male infertility. British Journal of Urology International 2001; 87: 417
14. Stewart E, Otite U, Nargund V H: A randomised prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: The Emory university experience. Journal of Urology 2001; 166: 1009
15. Sanghtani B K, Bharadwa J, Kapoor S, Pati J and Nargund V H. Is Microscopic haematuria a urological emergency? British Journal of Urology International 2003; 91: 3001
16. Gordon S, Bharadwa J, Campbell S, Nargund V H. Spermatogenesis and Spectral echo- Doppler traces from the main testicular artery. British Journal of Urology International 2003; 91: 897-8
17. Bharadwa J, Kumar P and Nargund V H. The aetiology, pathophysiology and management of chronic orchalgia. British Journal of Urology International 2003; 92: 491
18. Nargund V H. Renal tumours extending into renal vein and IVC: MRI and IVC exploration. Journal of Urology 2003:170; 1326
19. Bharadwa J, Nargund V H. Value of frozen section examination for the management of non-palpable incidental testicular tumours by Le Roy et al. European Urology 2004; 45: 390-2
20. Bhalani V K, Kapoor S, Pati J, Nargund V H. Re: Conservative management of small testicular tumours relative to carcinoma in situ prevalence. Journal of Urology 2005; 174(5): 2067
21. Georgakopoulos D, Albanis S, Nargund V H. Re: Transurethral resection of prostate. British Journal of Urology International 2007; 99; 464-5
22. Zaman F, Choudhury A, Masood J, Nargund VH. Management of Ureteral Obstruction Due to Advanced Malignancy: Optimizing Therapeutic and Palliative Outcomes E. Kouba, E. M. Wallen and R. S. Pruthi. Journal of Urology 2008; 180: 444-450. 2009 Jan 19 [Epub ahead of print]
23. Ismail M, Zaman F, Baithun S, Nargund V, Pati J, Masood J. Inguinal lymph node metastases from a testicular seminoma: a case report and a review of the literature. J Med Case Reports 2010; 25;4(1): 378 [Epub ahead of print].